Edition:
United States

Uniqure NV (QURE.OQ)

QURE.OQ on NASDAQ Stock Exchange Global Select Market

39.35USD
3:59pm EST
Change (% chg)

$0.94 (+2.45%)
Prev Close
$38.41
Open
$38.46
Day's High
$39.80
Day's Low
$38.14
Volume
98,702
Avg. Vol
116,497
52-wk High
$43.23
52-wk Low
$20.29

Chart for

About

Uniqure NV is a gene therapy company based in the Netherlands. The Company is engaged in the discovery, development and commercialization of single treatments with curative results for patients suffering from genetic and other severe diseases. The Company advances a focused pipeline of gene therapies that are developed both... (more)

Overall

Beta: 0.51
Market Cap(Mil.): $274.23
Shares Outstanding(Mil.): 25.63
Dividend: --
Yield (%): --

Financials

  QURE.OQ Industry Sector
P/E (TTM): -- 69.44 33.70
EPS (TTM): -- -- --
ROI: -- 8.92 14.45
ROE: -- 10.08 15.96

UniQure gene therapy shows promising result in mid-stage trial

Gene therapy company UniQure NV said on Friday its treatment for hemophilia B increased the levels of a protein that helps in blood clotting after 12 weeks in a relatively small study.

Feb 08 2019

UPDATE 2-UniQure gene therapy shows promising result in mid-stage trial

Feb 8 Gene therapy company UniQure NV said on Friday its treatment for hemophilia B increased the levels of a protein that helps in blood clotting after 12 weeks in a relatively small study.

Feb 08 2019

UniQure gene therapy shows rise in blood-clotting protein in trial

Feb 8 UniQure NV said on Friday its gene therapy to treat patients with a blood disorder, hemophilia B, increased the levels of a protein that helps in blood clotting after 12 weeks.

Feb 08 2019

Earnings vs. Estimates